학술논문
ERAS-601, a potent allosteric inhibitor of SHP2, synergistically enhances the efficacy of sotorasib/adagrasib and cetuximab in NSCLC, CRC, and HNSCC tumor models
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445